CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,016 | +26.4% | 73,986 | +3.2% | 0.00% | 0.0% |
| Q2 2023 | $1,595 | -14.3% | 71,687 | -16.6% | 0.00% | 0.0% |
| Q1 2023 | $1,862 | +7.1% | 85,961 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $1,738 | -99.9% | 85,534 | +2.3% | 0.00% | -50.0% |
| Q3 2022 | $2,145,000 | +17.5% | 83,619 | +8.9% | 0.00% | +100.0% |
| Q2 2022 | $1,825,000 | -27.9% | 76,756 | -31.7% | 0.00% | -50.0% |
| Q1 2022 | $2,530,000 | -96.5% | 112,439 | -96.9% | 0.00% | -84.6% |
| Q4 2021 | $71,796,000 | +2121.4% | 3,626,154 | +2108.0% | 0.01% | +1200.0% |
| Q3 2021 | $3,232,000 | +100.7% | 164,228 | +124.6% | 0.00% | 0.0% |
| Q2 2021 | $1,610,000 | -62.4% | 73,135 | -59.4% | 0.00% | -50.0% |
| Q1 2021 | $4,284,000 | -22.7% | 180,064 | -15.0% | 0.00% | -33.3% |
| Q4 2020 | $5,542,000 | +15.7% | 211,856 | -23.0% | 0.00% | 0.0% |
| Q3 2020 | $4,789,000 | +9.1% | 275,095 | +5.4% | 0.00% | 0.0% |
| Q2 2020 | $4,391,000 | +55.4% | 261,037 | +9.9% | 0.00% | +50.0% |
| Q1 2020 | $2,825,000 | +11.2% | 237,607 | +13.2% | 0.00% | +100.0% |
| Q4 2019 | $2,540,000 | +67.4% | 209,871 | +95.6% | 0.00% | 0.0% |
| Q3 2019 | $1,517,000 | +19.4% | 107,313 | -5.9% | 0.00% | 0.0% |
| Q2 2019 | $1,271,000 | +7.5% | 114,025 | +13.2% | 0.00% | 0.0% |
| Q1 2019 | $1,182,000 | +44.0% | 100,692 | +63.7% | 0.00% | 0.0% |
| Q4 2018 | $821,000 | -52.7% | 61,523 | -50.3% | 0.00% | 0.0% |
| Q3 2018 | $1,737,000 | +188.5% | 123,887 | +223.3% | 0.00% | 0.0% |
| Q2 2018 | $602,000 | +28.1% | 38,316 | +33.9% | 0.00% | – |
| Q1 2018 | $470,000 | -86.3% | 28,621 | -84.9% | 0.00% | -100.0% |
| Q4 2017 | $3,424,000 | +105.2% | 189,577 | +119.2% | 0.00% | +50.0% |
| Q3 2017 | $1,669,000 | +16.2% | 86,475 | -28.9% | 0.00% | 0.0% |
| Q2 2017 | $1,436,000 | +8.1% | 121,682 | +0.4% | 0.00% | +100.0% |
| Q1 2017 | $1,328,000 | +84.7% | 121,173 | +22.4% | 0.00% | 0.0% |
| Q4 2016 | $719,000 | +123.3% | 99,000 | +100.2% | 0.00% | – |
| Q3 2016 | $322,000 | +2827.3% | 49,459 | +2255.2% | 0.00% | – |
| Q2 2016 | $11,000 | -45.0% | 2,100 | -58.0% | 0.00% | – |
| Q4 2015 | $20,000 | +1900.0% | 5,000 | +1448.0% | 0.00% | – |
| Q3 2015 | $1,000 | -95.8% | 323 | -92.0% | 0.00% | – |
| Q2 2015 | $24,000 | -36.8% | 4,015 | -46.5% | 0.00% | – |
| Q1 2015 | $38,000 | +31.0% | 7,498 | -21.4% | 0.00% | – |
| Q4 2014 | $29,000 | +141.7% | 9,539 | +56.8% | 0.00% | – |
| Q3 2014 | $12,000 | +9.1% | 6,085 | +10.7% | 0.00% | – |
| Q2 2014 | $11,000 | -97.7% | 5,498 | -95.4% | 0.00% | -100.0% |
| Q1 2014 | $476,000 | +15766.7% | 119,004 | +9968.0% | 0.00% | – |
| Q4 2013 | $3,000 | +50.0% | 1,182 | -40.7% | 0.00% | – |
| Q3 2013 | $2,000 | -60.0% | 1,994 | -27.6% | 0.00% | – |
| Q2 2013 | $5,000 | – | 2,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |